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Abstract
Background: Animal models of para-renal cancer can provide useful information for the evaluation of tumor
response to loco-regional therapy experiments in solid tumors. The aim of our study was to establish a rabbit
para-renal cancer model using locally implanted VX2 tumors.
Methods: In order to generate a rabbit model of para-renal cancer, we established four hind limb donor rabbits by
using frozen VX2 tumor samples. Following inoculation, rabbits were monitored for appetite and signs of pain.
Viable tumors appeared as palpable nodules within 2 weeks of inoculation. Tumor growth was confirmed in all
rabbits by high-resolution ultrasound analysis and histology. Once tumor growth was established, hind limb tumors
extraction was used for tumor line propagation and para-renal tumor creation. Twenty-one rabbit models bearing
para-renal cancer were established by implanting VX2 tumor into the para-renal capsula. Tumors developed into
discreet 2–3 cm nodules within 1–3 weeks of implantation. Serial renal ultrasonography follow-up, starting 1 week
after tumor implantation, was performed. Two weeks after tumor implantation, rabbits were euthanized and tumors
and other organs were collected for histopathology.
Results: Tumor growth after VX2 tumor fragment implantation was confirmed in all rabbits by high-resolution
ultrasound (US) imaging examinations of the para-renal regions and was measured with digital caliper. The
para-renal injection of VX2 tumor fragments, achieved tumor growth in 100% of cases. All data were confirmed by
histological analysis.
Conclusions: We generated for the first time, a model of para-renal cancer by surgical tumor implantation of
VX2 frozen tumor fragments into rabbit’s para-renal region. This method minimizes the development of
metastases and the use of non-necrotic tumors and will optimize the evaluation of tumor response to loco-regional
therapy experiments.
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Background
The rabbit VX2 tumor model is frequently used in ex-
perimental oncology. The VX2 tumor is a leporine ana-
plastic squamous cell carcinoma induced by virus.
Hypervascularity, rapid growth and easy propagation in
the skeletal muscle, represent its features [1–4]. It is of
note that this model has been used to model various
types of cancer, including those of pancreas, kidney and
liver [5–15]. The transplantation of VX2 cells can be
achieved either by implanting solid tumor pieces or by
injecting the tumor cell suspensions (fresh or frozen) as
previously described [16].
Various form of multimodal neoadjuvant and adjuvant
treatments have been used in combination with surgery
to improve loco regional control of solid tumors having
a high incidence of local recurrence after resection, such
as rectal cancer [17–21], soft tissue sarcomas [22] and
pancreatic cancer [23, 24]. The present study describes
the establishment of a rabbit para-renal cancer model
using locally implanted VX2 frozen tumors. This cancer
model will be potentially used for the evaluation of
tumor response to multimodal treatment of solid tumors
with high risk of local recurrence after surgery.
Methods
Animal preparation
All experiments were carried out with the approval of
the Ethics Committee and the Italian Ministry of Health,
and the professional staff of the biotechnologies animal
research facility supervised the housing and care of the
rabbits. Twenty-five Male New Zealand White rabbits
(body weight of 2.5–3.5 kg) were initially fed with stand-
ard chow and water ad libitum for a week during adap-
tation in the animal research facility. After all the
surgical procedures and the treatments established by
the experimental protocol, the rabbits were placed in a
cage temporarily heated for the recovery of vital func-
tions and then were transferred to regular cages. All pro-
cedures were performed in a sterile environment.
VX2 tumor fragments preparation
VX2 tumor fragments (obtained by Prof. Agata Exner
from Case Western Reserve University Cleveland Ohio)
were stored in freeze media at – 80 °C until first use.
The vials containing tumor fragments were placed in a
37 °C water bath for a rapid but not complete thawing.
Tumor pieces were removed carefully from the cryo-
tubes with a sterile anatomic surgical forceps and placed
into a sterile Petri dish 100 mm × 20 mm (Corning Inc.,)
in ice. The medium contained 25 ml Dulbecco’s
Modified Eagle Medium/nutrient mixture F-12 with glu-
tamine (DMEM/F12, Aurogene) and 5% Fetal Bovine
Serum (FBS, Sigma-Aldrich). Subsequently, the frag-
ments were also washed in cold Hanks’ Balanced Salt
Solution (HBSS Euroclone). In both washing procedures,
the pieces were cleaned carefully 3 times. The tumor bits
were placed into a sterile Petri dish with 15 mL of cold
HBSS and were completely covered by ice until implant-
ation in animals.
VX2 hind limb tumor development and harvesting
Four NWZ rabbits were used to propagate the VX2
tumor in lower para-spinal muscles. All rabbits were
pre-anesthetized with a combination of medetomidine
(0.2 mg/kg), ketamine (10 mg/kg) and butorphanol
(0.5 mg/kg) pre-operatively. General anesthesia was in-
duced through oral endotracheal intubation with a fibre-
optic scope and was maintained with sevorane 2% and
ketamine hydrochloride (30 mg/kg i.v.). After anesthesia
and pre-operative skin preparation, an incision of 2.5 cm
was made on the right hind limb until reaching the
muscle belly. Two small tumor pieces of 5 mm3 each
were implanted into the quadriceps muscle of the hind
limb and the gap was sutured with prolene 4/0.
Hemostasis was confirmed and closure in layers with
interrupted sutures (vycril 2/0), was performed. A vi-
able tumor is evident as a palpable nodule of about
2,5 cm × 3 cm within 10–14 days after tumor im-
plantation. Tumor growth was confirmed by ultrason-
ography and then hind limb tumor extraction was
performed. Each rabbit, under general anesthesia re-
ceived a lethal injection of Tanax 1 ml/Kg, at sacri-
fice. Subsequently, skin preparation and an incision of
4–5 cm were made on the right hind limb until
reaching the surrounding tumor area. Two curvilinear
incisions were made within the muscle, in order to
remove the tumor mass en-bloc as described in Parvivian
et al.[16]. The explanted tumor was bisected in order to
detect any gross evidence of a necrotic core to obtain vi-
able peripheral tumor. The resected tumor masses were
put in a sterile 50 ml tube containing ~30 ml serum free
RPMI 1640, (Aurogene) with 3% Penicillin 10,000 IU/ml,
Streptomycin 10,000 ug/ml (Aurogene) and 1%
Amphotericin B, 250 ug/ml (Sigma-Aldrich) for 30 min.
Tumor tissues were placed into a 100 mm Petri dish, and
any visible non-tumor tissue, was trimmed away. The tis-
sue was minced into several pieces (about 5 mm3 each),
using a sterile scalpel (#10) and forceps. Tumor pieces
were rapidly washed in ~20 ml HBSS, ~20 ml DMEM/
F12 plus 5% FBS, 3 times each. Half of tumor tissues were
employed fresh to develop a para-renal tumor model,
while the remaining part was frozen to create a future
stock. Freezing procedure was performed by placing the
tumor pieces into cry vials of 5 ml containing ~3 ml of
freeze media 70% DMEM/F12, 20% FBS and 10% Diethyl
Sulfoxide (DMSO, Fisher Scientific). Cryovials were placed
in ice for 30 min, transferred at −20 °C for 2 h and then
stored at – 80 °C.
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Generation of VX2 para-renal tumor rabbit model
Twenty-one rabbits were used in this study, five of them
were implanted with fresh tumor tissues, while sixteen
with frozen tumor pieces. Immediately before the sacri-
fice of animals, we obtained samples of blood by aspir-
ation with a 24 guage needle from the rabbits ears.
The blood samples were centrifuged (3000 rpm, 5 min)
to isolate the plasma fraction. Baseline, and liver enzyme
(ALT, AST, GGT, Alkaline phosphatase) bilirubin and
Complete Blood Counts (CBC) were evaluated and re-
peated every 7 days, until the sacrifice of animals. For the
para-renal tumor implantation procedure, the recipient
rabbits received xipho-umbilical laparotomy. A blunt dis-
section was used to expose the peritoneum through the
avascular linea alba. Careful division of the peritoneum al-
lows exploring the peritoneal cavity. Intestinal mobilization
was performed and an incision of the left retroperitoneal
space supra renal capsule was made. A single tumor
fragment was then placed in this para-renal space. The in-
cision was closed with prolene 4/0. After confirmation of
hemeostasis, the abdominal wall incision was closed
(peritoneum and fascia with Vycril 2/0 in continuous su-
ture, the skin in interrupted sutures in silk 2/0). After all
the surgical procedures and the treatments established by
the experimental protocol, the rabbits were placed in a
cage temporarily heated for the recovery of vital functions
and then were transferred to regular cages. Daily observa-
tions were made regarding appetite, feces and urine
quantity and consistency, attitude and activity levels. Ap-
propriate treatment measures were employed to address
any abnormalities noted during the daily observation and
recorded in appropriate animal welfare sheets. Tumor
growth was assessed by in vivo ultrasound imaging.
In vivo high-resolution ultrasound imaging
High-resolution ultrasound (US) imaging examinations
were performed with a VisualSonicsVevo 2100 unit
Fig. 1 Hind limb VX2 tumor development. Picture reveals visible
subcutaneous hind limb tumors (arrows)
Fig. 2 High resolution US of rabbit thigh muscle at 7 (a-b) and 14 days (c-d) after VX2 tumor pieces implant. a-b In the context of the muscular
tissue two hypoecoic, irregular masses (arrows) are evident, their diameters are of a: 9 × 4, 2 × 6, 8 mm b: 11 × 9, 4 × 6 mm. c-d Two irregular
masses (arrows), hypoecoic, strongly inhomogeneous, are evident. They are increased in size, measuring: c: 7,2 × 5, 7 × 8,6 mm; d: 5,5 × 12, 6 × 7,3 mm
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(Visual Sonics Inc., Toronto, Canada) specifically cus-
tomized for animal research. Abdominal radiologist (F.I.)
with 5 years of experience in radiology and in small
animal imaging field, performed all the micro-US ex-
aminations. Each rabbit was positioned on a dedicated
table in supine position. Body temperature was moni-
tored by a rectal probe and maintained at 37.0 ± 0.5 °C
with a heating blanket regulated by a homoeothermic
blanket control unit of which the US unit is equipped. An
appropriate amount of heated sonographic gel (Aquasonic
100; Parker Laboratories, Inc, Fairfield, NJ) was ap-
plied on the abdomen. Images were acquired by using
a linear array (MS250D, Visual Sonics; frequency 13–
24 MHz), fixed on an appropriate arm to ensure a
stationary position and constant pressure on the de-
sired image plane. US examination was performed in
B-mode, with the following setting parameters: fre-
quency, 21 MHz; dynamic range, 65 dB; frame rate,
8; depth, 21 mm; width, 23 mm; transmit power,
100%; high line density. All imaging settings were
kept constant throughout imaging sessions for all ani-
mals. Animals were examined on the 7th and the
14th day after surgery focusing on the development
of heteroplastic tissue in the site of the surgical im-
plant and on the presence of hepatic metastases. In
each rabbit, micro-US was performed exploring all the ab-
dominal parenchymatous organs and the peritoneal
recesses in order to evaluate the presence of any paren-
chymal lesion or intra-retroperitoneal free fluid. Particu-
larly, the size, shape, and location of the kidneys were
detected and the peri and para renal spaces were explored.
When presence of new heteroplastic masses was detected,
their size and shape were assessed in the three orthogonal
planes.
Histological examination
The animals were euthanized under general anesthesia;
the kidneys were harvested and examined macroscopic-
ally and microscopically. Each organ was sliced into
5-mm slices, and the malignant lesions were deter-
mined by the consensus of two observers (L.M. and
F.T.). Representative samples were frozen, sectioned
in a cryostat at 5-lm thickness, and stained using rou-
tine hematoxylin and eosin for light microscopy.
Results
Generation of VX2 limb tumor rabbit model
Four rabbits were used as donors for development of
VX2 tumor in the lower para-spinal right muscle of each
rabbit’s hind limb. Two small tumor frozen pieces
(previously thawed in lukewarm water), were implanted
into the quadriceps muscle of each rabbit’s hind limb. A
viable tumor of about 2,5 cm × 3 cm was obtained after
10–14 days of tumor growth in each rabbit (Fig. 1).
Fig. 3 Hind limb VX2 tumor propagation. a Pictures reveales explanted hind limb tumor. b Tumor excited shows necrotic core (asterisk). c peripheral
viable tumor (arrowheads), and adherent muscle tissue (arrows)
Fig. 4 Histological analysis of hindlimb tumors after 14 days from implant. a-b Positive tumor cells were detected hindlimb tumor tissue without
presence of necrotic area. Magnifications: 10 X (a) and 20X (b)
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Tumor development and progression was confirmed and
monitored by high resolution US performed at 7 and
14 days after surgery, (Fig. 2a-d) detecting tumor as a
predominantly hypoecoic, inhomogeneous, irregular, in-
filtrating mass, growing in the muscular tissue. In order
to obtain the propagation of VX2 tumor line and para-
renal tumor creation, we performed hind limb tumor ex-
traction after the sacrifice of rabbits. The viable tumors
(Fig. 3a-c) were accurately treated as described above.
Half of tumor tissues were employed fresh to develop
the para-renal rabbit tumor model, while the remaining
part was frozen to create a stock. The presence of tumor
cells in tumor samples was confirmed by histological
analysis (Fig. 4a-b).
Generation of VX2 para-renal tumor rabbit model
In order to generate VX2 para-renal tumor rabbit model,
the recipient rabbits underwent a xipho-umbilical lapar-
otomy. A blunt dissection was used to expose the peri-
toneum through the avascular linea alba. Careful
division of the peritoneum allows exploring the periton-
eal cavity. Intestinal mobilization was performed and an
incision of the left retroperitoneal space supra renal cap-
sule was made. A single tumor fragment was then placed
Fig. 5 Surgical implantation of VX2 tumor in para-renal region of rabbits. a Picture shows the implantation region. b The incision of the left
retroperitoneal para-renal space. c Surgical implantation of VX2 tumor in para-renal region. d The para-renal incision closed with prolene 4/0
Fig. 6 High resolution US in longitudinal plane of the left suprarenal fossa 7 days after the implant of VX2 tumor fragments. An irregular mass,
inhomogeneous, hypoecoic is evident above the upper renal pole (arrow in a) with a diameter of 6,943 × 6,456 mm (b)
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in this para-renal space. A single tumor fragment was
then placed in para-renal region as showed in Fig. 5.
The complete surgical procedure was performed as pre-
viously described. Tumor growth was assessed by ultra-
sound high resolution US performed at 7 and 14 days
after surgery, it allowed detection of the tumors as an ir-
regular and inhomogeneous mass, hypoecoic, infiltrating
the surrounding tissue, as shown in Figs. 6 and 7 (a-b)
respectively. Two weeks after the tumors implantation,
rabbits were sacrificed and tumors and other organs,
such liver, lung and both kidneys were collected for
histopathology analysis (Fig. 8) (Fig. 9 and data not
shown). The histological analysis of the tumor after
7 days from tumor tissue implant, revealed the presence
of active tumor cells and percentage of 5% of necrotic
area. (Fig. 9a, b, c) The histological analysis of the tumor
after 14 days from tumor tissue implant, revealed the
presence of active tumor cells and percentage of 10% of
necrotic area (Fig. 9d, e, f ).
It is important to underline that the implantation of
tumor fragments achieved tumor growth in 100% of
case. To date this is the first report describing a rabbit
model of para-renal cancer by surgical tumor implant-
ation of frozen VX2 tumors.
Discussion
We generated a rabbit model of para-renal cancer by
surgical tumor implantation of VX2 frozen tumors into
rabbits para-renal region. The VX2 tumor is a leporine
anaplastic squamous cell carcinoma virus-induced, and
is characterized by rapid growth and hypervascularity.
The generation of this cancer model will minimize the
development of metastases and the use of non-necrotic
tumors. Moreover, with this method, the evaluation of
Fig. 7 High resolution US in longitudinal plane of the left suprarenal fossa 14 days after the implant of VX2 tumor fragments. The inhomogeneous
and hypoecoic mass detected in the upper renal pole increased in size (arrow in a) with a diameter of mass 17,903 × 22,633 mm (b)
Fig. 8 VX2 para-renal tumor in rabbit at 14 days from tumor piece implant. a-b The images show the surgical procedure for removal of the left
kidney and para-renal tumor in rabbit after 14 days from the implant of the VX2 tumor. c-d The measurement of the tumor, with the caliper, in
the para-renal area, reveals the presence of a 1,5 × 1,5 cm nodule. d Dissection of left kidney and tumor mass
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tumor response to loco-regional therapy experiments
will be optimized. Various forms of multimodal neoadju-
vant and adjuvant treatments have been used in combin-
ation with surgery to improve loco regional control of
solid tumors having a high incidence of local recurrence
after resection, such as rectal cancer [17–21], soft tissue
sarcomas [22] and pancreatic cancer [23, 24].
Our animal model can be used in the future experi-
ments, to test the safety and the efficacy, in the bed of
resection, of new medical-devices in the multimodal
treatment approach of solid tumors with high risk of
local recurrence after surgery.
Conclusions
We generated for the first time, a model of para-renal
cancer by surgical tumor implantation of VX2 frozen
tumor fragments into rabbit’s para-renal region. This
method minimizes the development of metastases and
the use of non-necrotic tumors and will optimize the
evaluation of tumor response to loco-regional therapy
experiments.
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Fig. 9 Analysis of histological sections of Vx2 tumor after 7, 14 days from tumor tissue implant. a, b, c The histological analysis of the tumor after
7 days from tumor tissue implant, reveals the presence of active tumor cells and percentage of 5% of necrotic area. d, e, f The histological
analysis of the tumor after 14 days from tumor tissue implant, reveals the presence of active tumor cells and percentage of 10% of necrotic area.
Magnifications: 20x and 40X (boxes)
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